Suppr超能文献

左甲状腺素治疗以及血清游离甲状腺素和游离三碘甲状腺原氨酸浓度。

Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations.

作者信息

Woeber K A

机构信息

Department of Medicine, University of California, San Francisco/Mount Zion, San Francisco 94143-1640, USA.

出版信息

J Endocrinol Invest. 2002 Feb;25(2):106-9. doi: 10.1007/BF03343972.

Abstract

Although the normal thyroid gland secretes both levothyroxine (L-T4) and levotriiodothyronine (L-T3), normalization of serum TSH with L-T4-replacement therapy alone in hypothyroidism is generally believed to result in a normal serum L-T3 and to reflect a euthyroid state. However several recent studies suggest that this may not be the case. Accordingly, the relationship between serum free L-T4 and free L-T3 was examined in 20 normal individuals (group A) and in 53 patients with chronic autoimmune thyroiditis, 18 with normal TSH on no L-T4-replacement (group B), and 35 with normal TSH on L-T4-replacement therapy for hypothyroidism (group C). Data were analyzed by applying a one-way analysis of variance with correction for multiple comparisons. Serum TSH values were very similar among the 3 groups. In groups A and B, mean serum free T4 and free T3 were very similar. In group C, the mean free T4 (16+/-2 pmol/l) was significantly higher than the values in groups A (14+/-1) and B (14+/-2) (p<0.001) and the mean free T3 lower (4.0+/-0.5 pmol/l vs 4.2+/-0.5, NS and 4.4+/-0.5, p<0.02). Consequently, the mean molar ratio of free T4 to free T3 was significantly higher in group C than the ratios in groups A and B (p<0.0001), despite very similar TSH values. These findings indicate that in hypothyroid patients L-T4-replacement, that is sufficient to maintain a normal serum TSH, is accompanied by a serum free T4 that is higher than that in untreated euthyroid patients or normal individuals and may not result in an appropriately normal serum free T3 concentration.

摘要

尽管正常甲状腺分泌左旋甲状腺素(L-T4)和左旋三碘甲状腺原氨酸(L-T3),但一般认为,仅用L-T4替代疗法使甲状腺功能减退患者血清TSH正常化,可使血清L-T3正常,并反映甲状腺功能正常状态。然而,最近的几项研究表明情况可能并非如此。因此,对20名正常个体(A组)、53例慢性自身免疫性甲状腺炎患者[其中18例未接受L-T4替代治疗且TSH正常(B组),35例接受L-T4替代治疗以治疗甲状腺功能减退且TSH正常(C组)]的血清游离L-T4和游离L-T3之间的关系进行了研究。采用单向方差分析并校正多重比较来分析数据。3组之间的血清TSH值非常相似。A组和B组的平均血清游离T4和游离T3非常相似。C组的平均游离T4(16±2 pmol/L)显著高于A组(14±1)和B组(14±2)(p<0.001),而平均游离T3较低(4.0±0.5 pmol/L,与4.2±0.5相比无显著差异,与4.4±0.5相比,p<0.02)。因此,尽管TSH值非常相似,但C组游离T4与游离T3的平均摩尔比显著高于A组和B组(p<0.0001)。这些发现表明,在甲状腺功能减退患者中,足以维持血清TSH正常的L-T4替代治疗,伴随着血清游离T4高于未治疗的甲状腺功能正常患者或正常个体,且可能不会导致血清游离T3浓度适当正常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验